“The Institute for Genomic Medicine at the University of California, San Diego aims to discover new pathways in human health and disease and translate these discoveries to clinical and preventive medicine. Our multidisciplinary physician-scientist teams integrate clinical phenotypes with genomic, transcriptomic, proteomic, metabolomic and signaling approaches to understand and treat genetic contributions to human disease.”
Illumina and the UCSD IGM-HTGF will be providing details of an RNA-Seq Grant Program at the seminar. Be sure to attend so you can learn how you can take advantage of this unique opportunity.
9:30 am - 2:00 pm
IGM Genomics Center
- The IGM Genomics Center offers Next Gen sequencing services including sample QC, library preparation, sequencing on Illumina and PacBio platforms, as well as Illumina Bead Array technology.
Kelly Frazer, PhD, was recognized as Women Who Mean Business at a luncheon sponsored by the San Diego Business Journal on November 13, 2013. The event, now in its 20th year, honors women business leaders who contribute to and make a significant difference at San Diego organizations. Dr. Frazer is an internationally renowned leader in the field of genome biology and medicine. She is founding chief of the Division of Genome Information Sciences at UC San Diego, director of the Bio-Computational Center at UC San Diego's Clinical and Translational Research Institute and, in March 2013, was named the director of UC San Diego Institute for Genomic Medicine.
IGM in the New York Times as Dr. Kang Zhang and Dr. Trey Ideker are interviewed on their findings from their epigenetic markers study published earlier this year in Molecular Cell. Click here to read Searching for Meaningful Markers of Aging. Read more...